CIP
PTCT icon

Chartwell Investment Partners’s PTC Therapeutics PTCT Stock Holding History

Chartwell Investment Partners’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-5,327
Closed -$212K – 440
2021
Q4 		$212K Sell
5,327
-173
-3% -$6.62K 0.01% 423
2021
Q3 		$205K Hold
5,500
– – 0.01% 427
2021
Q2 		$232K Buy
5,500
+52
+1% +$2.23K 0.01% 422
2021
Q1 		$258K Sell
5,448
-292
-5% -$17.3K 0.01% 413
2020
Q4 		$350K Sell
5,740
-1,299
-18% -$76.6K 0.01% 415
2020
Q3 		$329K Hold
7,039
– – 0.01% 408
2020
Q2 		$357K Sell
7,039
-2,567
-27% -$126K 0.01% 390
2020
Q1 		$429K Buy
9,606
+796
+9% +$40.1K 0.02% 371
2019
Q4 		$423K Buy
+8,810
New +$374K 0.01% 389

Other funds holding PTCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Chartwell Investment Partners's PTCT Position: Q1 2022 in Review

Chartwell Investment Partners sold out of PTC Therapeutics (PTCT) in Q1 2022, closing a stake of 5,327 shares — an estimated $212K sold.

Chartwell Investment Partners first reported a position in PTCT in Q4 2019 and held it in 9 quarters. The position peaked at $429K in Q1 2020. 183 funds tracked by Wall St. Rank hold PTCT as of Q1 2022.

  • Chartwell Investment Partners reported no remaining PTC Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Chartwell Investment Partners sold 5,327 PTC Therapeutics shares in Q1 2022, an estimated $212K.
  • Chartwell Investment Partners first reported a position in PTC Therapeutics in Q4 2019 and held it in 9 quarters.
  • Chartwell Investment Partners's PTC Therapeutics position peaked at $429K in Q1 2020.
  • 183 funds tracked by Wall St. Rank held PTC Therapeutics as of Q1 2022.

Based on Chartwell Investment Partners's 13F filing for Q1 2022, filed 26 Apr 2022.